Mandate

Vinge advises Aspiro in connection with a public takeover offer from S. Carter Enterprises

February 01, 2015

Vinge advises Aspiro AB (publ) in connection with the public takeover offer from Project Panther Bidco Ltd, indirectly owned by  S. Carter Enterprises, LLC, which is controlled by Shawn Carter. All shareholders of Aspiro are offered SEK 1.05 in cash per share in Aspiro and the total value of the offer amounts to approx. MSEK 464. The acceptance period for the offer is expected to begin on or about 19 February 2015 and expire on or about 11 March 2015. The offer is, inter alia, conditional upon that it is accepted to the extent that Panther becomes the owner of more than 90 per cent of the total number of shares in Aspiro and that Panther receives the necessary regulatory approvals for the acquisition.

Vinge’s team primarily consisted of Jesper Schönbeck, Johan Rickfors and Nils Fredrik Dehlin.

Aspiro is a media technology company in the forefront of the ongoing redefinition of music consumption. Through the subscription services WiMP and TIDAL, Aspiro offers a complete experience of higher HiFi quality. The platform encompasses audio, video and integrated editorial features. In parallel, Aspiro is a content provider to the online media industry through RADR, helping its partners to attract and retain visitors on their web sites. For more information, please visit www.aspiro.com

 

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025